|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.99 USD | +1.04% |
|
-.--% | +2.48% |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Revenues | 39Cr | 59Cr | 78Cr | 96Cr | 116.67Cr | ||
Total Revenues | 39Cr | 59Cr | 78Cr | 96Cr | 116.67Cr | ||
Cost of Goods Sold, Total | 14Cr | 20Cr | 23Cr | 26Cr | 30Cr | ||
Gross Profit | 25Cr | 38Cr | 55Cr | 71Cr | 87Cr | ||
Selling General & Admin Expenses, Total | 42Cr | 58Cr | 63Cr | 70Cr | 75Cr | ||
R&D Expenses | 16Cr | 26Cr | 33Cr | 42Cr | 48Cr | ||
Other Operating Expenses | 1.01Cr | 70.1L | 1.1Cr | - | - | ||
Other Operating Expenses, Total | 59Cr | 85Cr | 97Cr | 112.53Cr | 123.44Cr | ||
Operating Income | -34Cr | -46Cr | -42Cr | -42Cr | -37Cr | ||
Interest Expense, Total | -2L | -38L | -38L | -38L | -38L | ||
Interest And Investment Income | 20.2L | - | - | - | - | ||
Net Interest Expenses | 18.2L | -38L | -38L | -38L | -38L | ||
Currency Exchange Gains (Loss) | - | -25L | - | - | 43.37L | ||
Other Non Operating Income (Expenses) | 4L | 1.38Cr | 3.34Cr | 5.05Cr | 5.66Cr | ||
EBT, Excl. Unusual Items | -34Cr | -45Cr | -39Cr | -37Cr | -31Cr | ||
Restructuring Charges | - | - | -3.49Cr | - | - | ||
Merger & Related Restructuring Charges | - | -11L | -2.35Cr | - | -1.25Cr | ||
Gain (Loss) On Sale Of Investments | -22.7L | 88.91L | 4.25Cr | 3.78Cr | 2.23Cr | ||
EBT, Incl. Unusual Items | -34Cr | -45Cr | -41Cr | -33Cr | -30Cr | ||
Income Tax Expense | 31.74L | 62.93L | 3.61Cr | 1.04Cr | -54.13L | ||
Earnings From Continuing Operations | -34Cr | -45Cr | -44Cr | -35Cr | -30Cr | ||
Net Income to Company | -34Cr | -45Cr | -44Cr | -35Cr | -30Cr | ||
Net Income - (IS) | -34Cr | -45Cr | -44Cr | -35Cr | -30Cr | ||
Net Income to Common Incl Extra Items | -34Cr | -45Cr | -44Cr | -35Cr | -30Cr | ||
Net Income to Common Excl. Extra Items | -34Cr | -45Cr | -44Cr | -35Cr | -30Cr | ||
Per Share Items | |||||||
Net EPS - Basic | -1.82 | -1.62 | -1.47 | -1.07 | -0.86 | ||
Basic EPS - Continuing Operations | -1.82 | -1.62 | -1.47 | -1.07 | -0.86 | ||
Basic Weighted Average Shares Outstanding | 19Cr | 28Cr | 30Cr | 32Cr | 34Cr | ||
Net EPS - Diluted | -1.82 | -1.62 | -1.47 | -1.07 | -0.86 | ||
Diluted EPS - Continuing Operations | -1.82 | -1.62 | -1.47 | -1.07 | -0.86 | ||
Diluted Weighted Average Shares Outstanding | 19Cr | 28Cr | 30Cr | 32Cr | 34Cr | ||
Normalized Basic EPS | -1.12 | -1.01 | -0.81 | -0.72 | -0.56 | ||
Normalized Diluted EPS | -1.12 | -1.01 | -0.81 | -0.72 | -0.56 | ||
Supplemental Items | |||||||
EBITDA | -34Cr | -45Cr | -41Cr | -40Cr | -34Cr | ||
EBITA | -34Cr | -46Cr | -42Cr | -42Cr | -37Cr | ||
EBIT | -34Cr | -46Cr | -42Cr | -42Cr | -37Cr | ||
EBITDAR | -33Cr | -44Cr | -39Cr | -39Cr | -33Cr | ||
Total Revenues (As Reported) | 39Cr | 59Cr | 78Cr | 96Cr | 116.67Cr | ||
Effective Tax Rate - (Ratio) | -0.93 | -1.41 | -8.87 | -3.11 | 1.8 | ||
Current Domestic Taxes | 3L | 3L | 4L | 11.82L | -5L | ||
Current Foreign Taxes | 15.88L | 61.93L | 3.38Cr | 99.38L | 1.38Cr | ||
Total Current Taxes | 18.39L | 65.3L | 3.42Cr | 1.11Cr | 1.33Cr | ||
Deferred Domestic Taxes | - | - | 3T | -10L | 25T | ||
Deferred Foreign Taxes | 13.35L | -2L | 18.86L | 3L | -1.87Cr | ||
Total Deferred Taxes | 13.35L | -2L | 18.89L | -7L | -1.87Cr | ||
Normalized Net Income | -21Cr | -28Cr | -24Cr | -23Cr | -19Cr | ||
Supplemental Operating Expense Items | |||||||
Advertising Expense | 2.67Cr | 2.87Cr | 2.77Cr | 3.15Cr | 4.17Cr | ||
Selling and Marketing Expenses | 32Cr | 45Cr | 50Cr | 55Cr | 59Cr | ||
General and Administrative Expenses | 11Cr | 12Cr | 14Cr | 16Cr | 16Cr | ||
Research And Development Expense From Footnotes | 16Cr | 26Cr | 35Cr | 42Cr | 48Cr | ||
Net Rental Expense, Total | 1.02Cr | 1.01Cr | 2.09Cr | 49L | 49L | ||
Imputed Operating Lease Interest Expense | 27.83T | 3L | 6L | 1L | 1L | ||
Imputed Operating Lease Depreciation | 1.02Cr | 98.26L | 2.03Cr | 47.66L | 47.66L | ||
Stock-Based Comp., COGS (Total) | 1.8Cr | 3.24Cr | 3.67Cr | 3.64Cr | 3.35Cr | ||
Stock-Based Comp., R&D Exp. (Total) | 4.91Cr | 10Cr | 14Cr | 17Cr | 19Cr | ||
Stock-Based Comp., S&M Exp. (Total) | 5.55Cr | 9.94Cr | 12Cr | 13Cr | 12Cr | ||
Stock-Based Comp., G&A Exp. (Total) | 3.31Cr | 4.44Cr | 4.87Cr | 5.87Cr | 5.35Cr | ||
Total Stock-Based Compensation | 16Cr | 28Cr | 35Cr | 40Cr | 40Cr |
- Stock Market
- Stocks
- CFLT Stock
- Financials Confluent A
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















